Ausgabe 8/2015
Inhalt (7 Artikel)
Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen
Aurelia H. M. de Vries Schultink, Wilbert Zwart, Sabine C. Linn, Jos H. Beijnen, Alwin D. R. Huitema
A Comprehensive Review of Drug–Drug Interactions with Metformin
Tore Bjerregaard Stage, Kim Brøsen, Mette Marie Hougaard Christensen
Pharmacokinetics of Sublingual Buprenorphine and Naloxone in Subjects with Mild to Severe Hepatic Impairment (Child-Pugh Classes A, B, and C), in Hepatitis C Virus-Seropositive Subjects, and in Healthy Volunteers
Azmi F. Nasser, Christian Heidbreder, Yongzhen Liu, Paul J. Fudala
Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence
Jacqueline S. L. Kloth, Lisette Binkhorst, Annelieke S. de Wit, Peter de Bruijn, Paul Hamberg, Mei H. Lam, Herman Burger, Ines Chaves, Erik A. C. Wiemer, Gijsbertus T. J. van der Horst, Ron H. J. Mathijssen
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection
Florence Namour, Paul Matthias Diderichsen, Eugène Cox, Béatrice Vayssière, Annegret Van der Aa, Chantal Tasset, Gerben Van‘t Klooster
Population Pharmacokinetic Modeling of Guanfacine in Pediatric Patients
William Knebel, Mary Corcoran, James Ermer, Marc R. Gastonguay